SpectraMedix Blog | Raj Lakhanpal, MD, FACEP, CEO, SpectraMedix

By Raj Lakhanpal, MD, FACEP, CEO, SpectraMedix On January 5, 2022

Value-Based Care Predictions for 2022

As we leave a tough 2021 in the rear-view mirror, 2022 brings with it some optimism as recent data suggests that vaccinated...

( read )

By Raj Lakhanpal, MD, FACEP, CEO, SpectraMedix On November 17, 2021

As risk-bearing entities (Health Plans, ACOs, IPAs, etc.) continue to advance in value-based care (VBC), one area they can’t...

( read )

By Raj Lakhanpal, MD, FACEP, CEO, SpectraMedix On April 9, 2021

A risk bearing entity, whether it is a health plan, an ACO, or an IPA, should consider including SDoH contracting into their...

( read )

By Raj Lakhanpal, MD, FACEP, CEO, SpectraMedix On February 2, 2021

With more and more health plans, like Humana, announcing the development of value-based capitated payment programs, capitated...

( read )

By Raj Lakhanpal, MD, FACEP, CEO, SpectraMedix On December 8, 2020

For the past ten years social determinants of Health (SDoH) have gained greater importance from health care organizations and...

( read )

By Raj Lakhanpal, MD, FACEP, CEO, SpectraMedix On November 17, 2020

With a new president in office, the entire country is wondering how one of Biden’s major platforms—healthcare reform—will...

( read )

By Raj Lakhanpal, MD, FACEP, CEO, SpectraMedix On October 29, 2020

Since February 2020, COVID-19 has continued its course throughout the United States. As the year comes to a close,...

( read )